Inventor · disambiguated record
Cecilia Pui Chi Chiu
Also filed as: CHIU CECILIA · CHIU CECILIA P C · CHIU CECILIA PUI CHI
19 granted patents·8 pending applications·36 citations·filing 2011–2024
92Inventor score
Top patents by PatentIndex Score
27 records- 0189US9522954B2Anti-LRP5 antibodies and methods of useGENENTECH INC·Filed 2015·Granted Dec 20, 2016·3 cites·31 claims
- 0288US9453079B2Methods and compositions for neural disease immunotherapyGENENTECH INC·Filed 2014·Granted Sep 27, 2016·9 cites·35 claims
- 0387US10501545B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2016·Granted Dec 10, 2019·6 cites·31 claims
- 0485US10266597B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2017·Granted Apr 23, 2019·3 cites·99 claims
- 0585US9266961B2Anti-PCSK9 antibodies, formulations, dosing, and methods of useGENENTECH INC·Filed 2013·Granted Feb 23, 2016·8 cites·42 claims
- 0683US11008403B2Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of useGENENTECH INC·Filed 2015·Granted May 18, 2021·3 cites·25 claims
- 0778US10239947B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2017·Granted Mar 26, 2019·1 cites·80 claims
- 0878US10227412B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2017·Granted Mar 12, 2019·1 cites·18 claims
- 0975US9751946B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2015·Granted Sep 5, 2017·1 cites·96 claims
- 1073US11084877B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2019·Granted Aug 10, 2021·0 cites·5 claims
- 1167US11746160B2Antibodies against BACE1 and use thereof for neural disease immunotherapyGENENTECH INC·Filed 2020·Granted Sep 5, 2023·0 cites·6 claims
- 1264US8772457B2BACE1 antibodiesATWAL JASVINDER·Filed 2011·Granted Jul 8, 2014·1 cites·28 claims
- 1364US2019010228A1Anti-lrp5 antibodies and methods of useGENENTECH INC·Filed 2018·Application pending·0 cites
- 1463US11466087B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 1563US2024360229A1Multispecific antibodies and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1662US12312414B2Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of useGENENTECH INC·Filed 2020·Granted May 27, 2025·0 cites·49 claims
- 1762US11845799B2Anti-Ly6G6D antibodies and methods of useGENENTECH INC·Filed 2020·Granted Dec 19, 2023·0 cites·44 claims
- 1862US10035854B2Method of treating retinopathy with an anti-LRP5 antibodyGENENTECH INC·Filed 2016·Granted Jul 31, 2018·0 cites·30 claims
- 1960US2024327522A1Anti-alpha v beta 8 integrin antibodies and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 2059US9200072B2Anti-LRP5 antibodies and methods of useGENENTECH INC·Filed 2013·Granted Dec 1, 2015·0 cites·35 claims
- 2158US2024084042A1Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 2257US10882920B2Antibodies against BACE1 and use thereof for neural disease immunotherapyGENENTECH INC·Filed 2015·Granted Jan 5, 2021·0 cites·21 claims
- 2356US2023322958A1Anti-Notch2 Antibodies and Conjugates and Methods of UseGENENTECH INC·Filed 2023·Application pending·0 cites
- 2455US9879094B2Nucleic acid molecules encoding for BACE1 antibodiesGENENTECH INC·Filed 2016·Granted Jan 30, 2018·0 cites·27 claims
- 2549US2023303682A1Anti-Notch2 Antibodies and Methods of UseGENENTECH INC·Filed 2021·Application pending·0 cites
- 2643US2016355606A1Anti-pcsk9 antibodies, formulations, dosing, and methods of useGENENTECH INC·Filed 2015·Application pending·0 cites
- 2737US2012195910A1Anti-pcsk9 antibodies and methods of useWU YAN·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →